Give to GCHS

Global Center for Health Security

- Our Expertise Overview
- Why Nebraska?
  Nebraska’s difference is an all-star, all-volunteer team that dedicated itself to being ready for any biocontainment crisis at any time.
- Leadership
  The Global Center is led by experts in biopreparedness and high-consequence infections research, education and clinical care.
- Scholars
  Our scholars are leading advancements in global health security.
- Affiliates
  Our affiliates are innovative experts collaborating to advance global health security.
- C-STARS
  C-STARS, the Center for Sustainment of Trauma Readiness Skills- Omaha is a collaboration between UNMC, Nebraska Medicine, and the Air Force Research Laboratory’s School of Aerospace Medicine. C-STARS Omaha works closely with UNMC’s Global Center for Health Security, iEXCEL, and the Nebraska Biocontainment Unit to take advantage of the medical center’s capabilities and expertise in biopreparedness training and research.
- Our Team
  Our team consists of a variety of professionals providing support and project management to further the Global Center for Health Security’s mission.
- Domains Overview
- Clinical Operations
  The Global Center for Health Security is the premier U.S. institution for management of high-consequence infections. Further, our clinical capabilities include biological, chemical, burn, and radiation domains.
- Education & Training
  Our expertise is now sought worldwide and officially sanctioned by the U.S. government. The GCHS is the home base to the national Training, Simulation, and Quarantine Center and the Nebraska Biocontainment Unit.
- Research
  The GCHS has laser-focused existing work by our leading scientists in fields like chemical weapons, drug discovery and public health.
- Innovation & External Partnerships
  The GCHS has partnered with many academic groups at UNMC and external partners to tackle the most pressing problems in emerging infectious diseases.
Programs
- Health Emergencies Overview
- Outbreaks to Watch
  Find information about emerging pathogens, diseases and outbreaks from around the world. Stay updated on the most recent information on worldwide global health and emerging pathogens outbreaks.
- COVID-19
  Explore our COVID-19 page for recent news, resources, manuals, and playbooks. Biweekly overviews of new data and developments presented by James V. Lawler, MD, MPH, FIDSA can now be found on the Health Emergencies page.
- HPAI H5N1- Avian Influenza
  Learn more about the current worldwide outbreak of HPAI H5N1- Avian Influenza and explore resources, news, webinars, and our unofficial map.
- Marburg Virus Disease
  Explore this page for more information, resources, news, and situational updates about the current Marburg outbreak in Rwanda.
- Mpox
  The Global Center for Health Security is currently monitoring the spread of mpox. Learn more by viewing our resources.
- Dengue Fever
  The GCHS is currently monitoring the rise of Dengue Fever. This page provides information, resources, and news.
The Transmission
- News Overview
- Highlights
  Read recent highlights, articles, events, recognition and updates on the work of our programs and partners.
- Events
  Find scheduled and past events involving the Global Center for Health Security.
- Annual Reports
  Find annual reports for our center and several of our programs.

— Global Center for Health Security — The Transmission — Category: Vaccine Headlines

Category: Vaccine Headlines

Vaccine Headlines

FDA Finds Flaws at Vaccine Factory, Accepts Moderna’s Assurances

Bloomberg – FDA inspectors found that particles in Moderna’s Covid-19 vaccine made by Catalent weren’t adequately looked into by the company.

Sep 22, 2022

Vaccine Headlines

Updated COVID booster tied to strong Omicron immune response

CIDRAP – The new bivalent (two-strain) Moderna COVID-19 vaccine booster triggered stronger neutralizing antibody responses against the highly transmissible Omicron variant at 28 days than the previously authorized booster, with no safety concerns, according to the interim results of a phase 2/3 open-label, nonrandomized study published late last week in the New England Journal of Medicine.

Sep 22, 2022

Vaccine Headlines

When should I get the omicron booster?

Washington Post – The broad protection from these updated shots — called bivalent boosters — could prevent more than 100,000 hospitalizations in the coming months, according to one estimate. But many people still have questions about who should get the new booster, the best timing for the shot and if it would be better to delay […]

Sep 22, 2022

Vaccine Headlines

Moderna Booster Shots Are in Short Supply at US Pharmacies

Bloomberg – The US government supply of Moderna’s shot is currently limited, causing appointments for the product to vary across the country, a Walgreens Boots Alliance Inc. pharmacy spokesperson said in an emailed statement. CVS Health Corp. says some of its drugstores have used all of the updated shots they received from the US government, and the company is […]

Sep 22, 2022